日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Somatic and germline genomic variation in thymic carcinomas

胸腺癌的体细胞和种系基因组变异

Tettamanzi, F; De Carlo, C; Cappadona, C; Giuliano, D; Rimoldi, V; Piombo, C; Cecchi, L G; Zanella, S; Marulli, G; Voulaz, E; Veronesi, G; Marchini, S; Di Tommaso, L; Zucali, P A; Asselta, R

Final results of DIADEM, a phase II study to investigate the efficacy and safety of durvalumab in advanced pretreated malignant pleural mesothelioma

DIADEM 的最终结果,这是一项 II 期研究,旨在研究度伐利尤单抗治疗晚期既往接受过治疗的恶性胸膜间皮瘤的疗效和安全性。

Canova, S; Ceresoli, G L; Grosso, F; Zucali, P A; Gelsomino, F; Pasello, G; Mencoboni, M; Rulli, E; Galli, F; De Simone, I; Carlucci, L; De Angelis, A; Belletti, M; Bonomi, M; D'Aveni, A; Perrino, M; Bono, F; Cortinovis, D L

Role of proton-coupled folate transporter in pemetrexed resistance of mesothelioma: clinical evidence and new pharmacological tools

质子偶联叶酸转运蛋白在间皮瘤培美曲塞耐药中的作用:临床证据和新的药理学工具

Giovannetti, E; Zucali, P A; Assaraf, Y G; Funel, N; Gemelli, M; Stark, M; Thunnissen, E; Hou, Z; Muller, I B; Struys, E A; Perrino, M; Jansen, G; Matherly, L H; Peters, G J

MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patients

MET基因拷贝数增加,导致非小细胞肺癌患者对吉非替尼治疗产生原发性耐药。

Cappuzzo, F; Jänne, P A; Skokan, M; Finocchiaro, G; Rossi, E; Ligorio, C; Zucali, P A; Terracciano, L; Toschi, L; Roncalli, M; Destro, A; Incarbone, M; Alloisio, M; Santoro, A; Varella-Garcia, M

Role of cMET expression in non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitors.

cMET表达在接受EGFR酪氨酸激酶抑制剂治疗的非小细胞肺癌患者中的作用

Zucali P A, Ruiz M G, Giovannetti E, Destro A, Varella-Garcia M, Floor K, Ceresoli G L, Rodriguez J A, Garassino I, Comoglio P, Roncalli M, Santoro A, Giaccone G